Posting of Circular

RNS Number : 5891N
MyHealthChecked PLC
01 February 2021
 

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED.  ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

MyHealthChecked plc

( " MyHealthChecked " or " the Company " )

 

Posting of Circular

 

Further to the announcement of 29 January 2021, MyHealthChecked plc (AIM: MHC),   the consumer home-testing healthcare company, confirms it has today posted a circular to shareholders, which explains the background to and reasons for the Fundraising. The Circular contains the Notice of General Meeting to be held on 18 February 2021. A copy of the Circular and Notice of General Meeting is available on the Company's website: www.myhealthcheckedplc.com

 

Capitalised terms not otherwise defined in this announcement shall have the same meaning ascribed to such terms in the announcement released on 29 January 2021 unless the context requires otherwise.

 

For further information please contact:

 

 

MyHealthChecked plc

www.myhealthcheckedp lc .com

P enny McCormick , Chief Executive Officer

via Walbrook PR

Maddy Kennedy, Chief Financial Officer




SPARK Advisory Partners Limited (NOMAD)

Tel: +44 (0)20 3368 3550

Neil Baldwin




Oberon Investments  (Broker)

Tel: +44 (0)203 179 5344

Mike Seabrook

mikeseabrook@oberoninvestments.com



Walbrook PR Ltd (Media & Investor Relations)

Tel: +44 (0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com

Paul McManus

Mob: +44(0)7980 541 893

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUPUUUPUPGGCG
UK 100

Latest directors dealings